IMW 2019 | Daratumumab consolidation therapy in MM

Alessandro Gozzetti

Alessandro Gozzetti, MD, PhD, Sense University Hospital, Siena, Italy, discusses the use of daratumumab as consolidation therapy, in particular after autologous STEM cell transplantation in multiple myeloma (MM) patients, speaking at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video